vialauditThe Roundup
ORFORGLIPRON·US LEGAL STATUS·LAST CHECKED 12 OCT 2026

Is Orforglipron legal?

Yes, as a prescription drug: FDA has approved it (Foundayo). A vial sold as a 'research peptide' is not the approved product, and selling it for human use breaks federal drug law. Pharmacies may compound it only when the product is not a copy of the approved drug.

RESEARCH-LABELLED SALE
Unapproved copy of an Rx drug
PHARMACY COMPOUNDING
Only if not a copy
PRESCRIPTION
FDA-approved (Foundayo)
WADA 2026
Not listed

DESCRIBES THE LAW · NOT LEGAL ADVICE · NO DOSING INFORMATION

Federal, compounding and sport status

CHECKED 12 OCT 2026

Federal status

FDA approval
approved as drug · brand: Foundayo · NDA 220934 · approved Apr 1, 2026
Indications: chronic weight management in adults with obesity or overweight with weight-related comorbidity
DEA scheduling
not scheduled
503A compounding
FDA interim category: Component of an FDA-approved drug
503A Bulks List: not on list
FDA approved orforglipron as Foundayo on 1 Apr 2026, so it is now a component of an approved drug. A 503A copy of the commercial product would fall under the 'essentially a copy' bar. Not on any shortage list.
FDA Warning Letters
none on record for this compound
Shortage status
not currently on shortage list
Sale framing
Research-use-only posture: As an approved drug, 'research peptide' sales would be unapproved diversion + FDCA violation. No warning letters yet (new approval).
Personal possession: Not federally criminalized; controlled by prescription via LillyDirect.

Sport-body status

WADA 2026
not prohibited
Approved in the US since 1 Apr 2026; GLP-1 receptor agonists are not on the 2026 Prohibited List.
USADA
not banned
NCAA
unknown

What we couldn’t verify

State rules

NONE FOUND

We found no state statute, board rule or enforcement action that names Orforglipron. The federal position above applies in all 50 states and DC.

What changed at the last check

3 CHANGES
DateFieldWasNowWhy
12 Oct 2026WADA 2026prohibited (S2)not prohibitedApproved in the US since 1 Apr 2026; GLP-1 receptor agonists are not on the 2026 Prohibited List. source ↗
12 Oct 2026FDA approvalinvestigationalapproved as drugFDA approved orforglipron as Foundayo on 1 Apr 2026 (NDA 220934). source ↗
12 Oct 2026IN state noteIndiana SB 282 GLP 1 med spa registration regime reaches orforglipron as an in scope GLP 1.removedRemoved. The entry described a IN action that does not name Orforglipron; it applied federal-level or class-wide facts by analogy. source ↗

Questions

3 ANSWERS
Is Orforglipron legal in the US?

Yes, as a prescription drug: FDA has approved it (Foundayo). A vial sold as a 'research peptide' is not the approved product, and selling it for human use breaks federal drug law. Pharmacies may compound it only when the product is not a copy of the approved drug.

Can a pharmacy compound Orforglipron?

FDA approved orforglipron as Foundayo on 1 Apr 2026, so it is now a component of an approved drug. A 503A copy of the commercial product would fall under the 'essentially a copy' bar. Not on any shortage list.

Is Orforglipron banned in sport?

It is not on the WADA 2026 Prohibited List. Approved in the US since 1 Apr 2026; GLP-1 receptor agonists are not on the 2026 Prohibited List.

Sources

4 DOCUMENTS
  1. FDA approval record
  2. DEA controlled-substance schedules
  3. WADA 2026 Prohibited List
  4. Source for: IN state note
THE ROUNDUP · MONTHLY

Receipts in your inbox. Once a month.

New audits, expired coupons pruned, lab notes from vials still on the bench. No marketing. No lifestyle copy. Unsubscribe in one click.

14,200 SUBSCRIBERS·0 SPONSORED ITEMS·11 ISSUES SINCE LAUNCH